Proteon Therapeutics, Inc. (PRTO) insider have most recently took part in a trading activity. On Dec 15, 2017 Burke Steven Keith, SVP and Chief Medical Officer bought 12,000 shares having total worth of $22,560 at the price of $1.88 per share, following the transaction a total of 127,534 shares owned by Burke Steven Keith.
The stock has experienced a total of 2 insider trades in the past three months. These trades include 1 sell activities and 1 buy trades. Furthermore, over the past 12 months , the stock was traded 2 times by insiders. In 1 of these trades, the insider was a seller while an employee of the company was the buyer in 1 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Proteon Therapeutics, Inc. (PRTO) last announced its earnings results on Nov 7, 2017. The company reported -0.70 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.39 by $0.31. During the same quarter in the previous year, the company posted -0.43 earnings per share.
|earnings per share||-0.70||-0.33||-0.39||-0.43||-0.48||-0.40||-0.38||-0.33||-0.31||-0.28|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018